Literature DB >> 8780636

Re:Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.

M Guffroy, T Hodge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8780636     DOI： 10.1093/jnci/88.17.1240

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11).

Authors:  J P Duong Van Huyen; F Bloch; A Attar; D Levoir; C Kreft; T Molina; P Bruneval
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

2.  IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.

Authors:  R Guabiraba; A G Besnard; G B Menezes; T Secher; M S Jabir; S S Amaral; H Braun; R C P Lima-Junior; R A Ribeiro; F Q Cunha; M M Teixeira; R Beyaert; G J Graham; F Y Liew
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.